Italy pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$41.5 billion | 75.5% |
| 3002 Human blood | US$11.9 billion | 21.6% |
| 3003 Medicaments | US$683.3 million | 1.2% |
| 3006 Pharmaceutical goods | US$645.8 million | 1.2% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$205.2 million | 0.4% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$92.6 million | 0.2% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$28.6 billion | 51.9% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$8.4 billion | 15.2% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$7.5 billion | 13.7% |
| 300220 Vaccines: for human medicine | US$3.2 billion | 5.8% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$3.1 billion | 5.6% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$1.2 billion | 2.2% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$484.8 million | 0.9% |
| 300630 Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | US$431.2 million | 0.8% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$380.7 million | 0.7% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$312.7 million | 0.6% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$18.3 billion | 57.0% |
| 3002 Human blood | US$12.5 billion | 38.9% |
| 3006 Pharmaceutical goods | US$478.7 million | 1.5% |
| 3003 Medicaments | US$424.8 million | 1.3% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$257.0 million | 0.8% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$131.6 million | 0.4% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$15.7 billion | 49.0% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$10.3 billion | 32.0% |
| 300220 Vaccines: for human medicine | US$1.6 billion | 5.1% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$1.6 billion | 4.9% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$466.2 million | 1.5% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$349.7 million | 1.1% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$327.8 million | 1.0% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$219.3 million | 0.7% |
| 300610 Pharmaceutical goods: sterile surgical catgut, suture materials, tissue adhesives, laminaria, laminaria tents and absorbable surgical or dental haemostatics | US$174.2 million | 0.5% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$151.0 million | 0.5% |
Shares are of Italy's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Italy's trade.
More Italy products
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 27 Mineral fuels, mineral oils and products of their distillation
- 87 Vehicles
- 85 Electrical machinery and equipment and parts thereof
- 29 Organic chemicals
- 71 Natural, cultured pearls
- 39 Plastics and articles thereof
- 72 Iron and steel
- 73 Iron or steel articles
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 62 Apparel and clothing accessories
- 22 Beverages, spirits and vinegar
Italy pharmaceutical products: questions and answers
How much pharmaceutical products does Italy export?
In 2024, Italy exported US$55.0 billion of pharmaceutical products (HS chapter 30), 8.7% of its total exports. That ranks it 6 of 213 exporting countries in the data.
What are Italy's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$41.5 billion), Human blood (3002, US$11.9 billion), Medicaments (3003, US$683.3 million).
How much pharmaceutical products does Italy import?
In 2024, Italy imported US$32.0 billion of pharmaceutical products (HS chapter 30), 5.4% of its total imports. That ranks it 8 of 226 importing countries in the data.
What are Italy's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$18.3 billion), Human blood (3002, US$12.5 billion), Pharmaceutical goods (3006, US$478.7 million).
